Author

V. O. Gawriljuk

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

A. C. Puhl· 1 shared A. S. Godoy· 1 shared D. H. Foil· 1 shared G. Olivia· 1 shared J. Bernatchez· 1 shared J. L. Siqueira-Neto· 1 shared J. Ricketts· 1 shared K. M. Zorn· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. C. Puhl

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivJun 16, 2020

Machine Learning Models Identify Inhibitors of SARS-CoV-2

V. O. Gawriljuk, P. P. Kyaw Zin, D. H. Foil…·S. Ekins

The paper uses machine learning to predict SARS-CoV-2 inhibitors from FDA-approved compounds, identifying CPI1062 and CPI1155 as potential antiviral drugs.

DOI 10.1021/acs.jcim.1c00683

proteomicsmachine learning (classical)

𝕏 PostBluesky